News-Papers
Testimonial
Video Gallery
Powered by Phoca Gallery
Search
Follow us...
Latest
- THERAPY WITH SOMATOSTATIN ANALOGUES IN PATIENTS WITH CASTRATION-REFRACTORY PROSTATE CANCER
- Drug therapy methods in patients with metastatic castration-resistant prostate cancer: Role of somatostatin analogues
- Antitumour activity of melatonin in a mouse model of human prostate cancer: relationship with hypoxia signalling
- The Role of Melatonin in Colorectal Cancer
- Cellular mechanisms involved in the melatonin inhibition of HT-29 human colon cancer cell proliferation in culture
- Bromocriptine monotherapy overcomes prostate cancer chemoresistance in preclinical models
- Melatonin Induces Apoptosis and Inhibits the Proliferation of Cancer Cells via Reactive Oxygen Species-mediated MAPK and mTOR Pathways
- Melatonin cytotoxicity in human leukemia cells: relation with its pro-oxidant effect
- Five years survival in metastatic non-small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: a randomized trial
- Melatonin as a modulator of apoptosis in B-Lymphoma Cells
- Melatonin promotes apoptosis of thyroid cancer cells via regulating the signaling of microRNA-21 (miR-21) and microRNA-30e (miR-30e)
- Somatostatin receptor 2 (SSTR2) expression is associated with better clinical outcome and prognosis in rectal neuroendocrine tumors
- Melatonin Inhibits Chemical Carcinogen-mediated Malignant Transformation of Urothelial Cells: In Vitro Evidence
- Resolution of Breast Cancer in a Patient With Thyroid Stimulating Hormone-Secreting Pituitary Neuroendocrine Tumor With the Combination of Chemotherapy and Lanreotide
- Novel Detection of Pleomorphic Adenomas via Analysis of 68Ga-DOTATOC PET/CT Imaging
- Somatostatin receptor 2A expression in von Hippel-Lindau-related hemangioblastomas
- Melatonin inhibits proliferation, migration, and invasion by inducing ROS-mediated apoptosis via suppression of the PI3K/Akt/mTOR signaling pathway in gallbladder cancer cells
- Melatonin induces the apoptosis and inhibits the proliferation of human gastric cancer cells via blockade of the AKT/MDM2 pathway
Most Read
- The Di Bella Method (DBM)
- All-trans-retinoic acid and cancer
- About melatonin - 1996
- Biography
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Somatostatin in oncology, the overlooked evidences
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- Bibliography
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- How effective is chemo therapy?
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
- Vademecum
- Complete objective response to biological therapy of plurifocal breast carcinoma
- Frequently Asked Questions
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Di Bella Method's improved survival, objective response and performance status in a retrospective observational clinical study on 55 cases of Lymphomas
- Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients